Application of blood purification to non-renal organ failure

International Journal of Artificial Organs

Volumn 28, Issue 5, 2005, Pages 445-449

  Kellum, John A ^a   Venkataraman, R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Continuous renal replacement therapy; Hemo adsorption; Hemofiltration; High flux dialysis; High volume hemofiltration

Indexed keywords

ARTIFICIAL ORGANS; BLOOD; CLINICAL RESEARCH; COMPLEX NETWORKS; INTENSIVE CARE UNITS; PURIFICATION;

CONTINUOUS RENAL REPLACEMENT THERAPY; HEMO-ADSORPTION; HEMOFILTRATION; HIGH FLUX; HIGH VOLUMES; HIGH-FLUX DIALYSIS; HIGH-VOLUME HEMOFILTRATION; ORGAN FAILURE; RENAL REPLACEMENT THERAPIES;

DIALYSIS;

ACUTE KIDNEY FAILURE; ARTIFICIAL LIVER; CLINICAL TRIAL; DEATH; EDITORIAL; EVIDENCE BASED MEDICINE; GUILLAIN BARRE SYNDROME; HEART FAILURE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; IMMUNOMODULATION; LIVER FAILURE; LIVER TRANSPLANTATION; MULTIPLE ORGAN FAILURE; NONHUMAN; PLASMAPHERESIS; SAFETY; SEPSIS; SEPTIC SHOCK; SYSTEMATIC REVIEW; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; ULTRAFILTRATION;

EID: 20444475726     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880502800504     Document Type: Editorial

References (23)

1. Kellum JA, Johnson JP, Kramer D, Palevsky P, Brady JJ, Pinsky MR. Diffusive vs convective therapy: Effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med 1998; 26: 1995-2000.
2. Bellomo R, Kellum JA, Gandhi CR, Pinsky MR, Ondulik B. The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 2000; 161: 1429-36.
3. Kellum JA, Dishart MK. Effect of hemofiltration filter adsorption on circulating IL-6 levels in septic rats. Crit Care 2002; 6: 429-33.
4. Kellum JA, Song M, Venkataraman R. Hemoadsorption removes TNF, IL-6 and IL-10, reduces NFB DNA binding and improves short-term survival in lethal endotoxemia. Crit Care Med 2004; 32: 801-5.
5. Kellum JA. Primum non nocere and the meaning of modern critical care. Curr Opin Crit Care 1998; 4: 400-5.
6. Tetta C, Bellomo R, Brendolan A, et al. Use of adsorptive mechanisms in continuous renal replacement therapies in the critically ill. Kidney Int 1999; 56 (suppl 72): S15-9.
7. Ronco C, Brendolan A, Lonnemann G, et al. A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 2002; 30: 1250-5.
8. Lockwood CM, Worlledge S, Nicholas A. Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med 1979; 300: 524-30.
9. Schroeder JO, Euler HH, Loffler H. Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus. Ann Intern Med 1987; 107: 344-50.
10. Rock GA, Shumak KH, Buskard NA. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991; 325: 393-9.
11. Busund R, Lindsetmo RO, Rasmussen LT, Rokke O, Rekvig OP, Revhaug A. Tumor necrosis factor and interleukin 1 appearance in experimental gram-negative septic shock. The effects of plasma exchange with albumin and plasma infusion. Arch Surg 1991; 126: 591-7.
12. Busund R, Lindsetmo RO, Balteskard L, Rekvig OP, Revhaug A. Repeated plasma therapy induces fatal shock in experimental septicemia. Circ Shock 1993; 40: 268-75.
13. Natanson C, Hoffman WD, Koev LA, Dolan DP, Banks SM, Bacher J, Danner RL, Klein HG, Parrillo JE. Plasma exchange does not improve survival in a canine model of human septic shock. Transfusion 1993; 33: 243-8.
14. Leese T, Holliday M, Heath D, Hall AW, Bell PR. Multicentre clinical trial of low volume fresh frozen plasma therapy in acute pancreatitis. Br J Surg 1987; 74: 907-11.
15. Gardlund B, Sjolin J, Nilsson A, Roll M, Wickerts CJ, Wretlind B. Plasma levels of cytokines in primary septic shock in humans: Correlation with disease severity. J Infect Dis 1995; 172: 296-301.
16. Stegmayr B. Apheresis of plasma compounds as a therapeutic principle in severe sepsis and multiorgan dysfunction syndrome. Clin Chem Lab Med 1999; 37: 327-32.
17. Stegmayr BG. Plasmapheresis in severe sepsis or septic shock. Blood Purif 1996; 14: 94-101.
18. Mok Q, Butt W. The outcome of children admitted to intensive care with meningococcal septicaemia. Intensive Care Med 1996; 22: 259-63.
19. Berlot G, Gullo A, Fasiolo S, Serra L, Silvestri L, Worz M. Hemodynamic effects of plasma exchange in septic patients: Preliminary report. Blood Purif 1997; 15: 45-53.
20. Carcillo JA, Kellum JA. Is there a role for plasmapheresis/plasma exchange therapy in septic shock, MODS, and thrombocytopenia-associated multiple organ failure? We still do not know - but perhaps we are closer. Intensive Care Med 2002; 28: 1373-5.
21. Busund R, Koukline V, Utrobin U, Nedashkovsky E. Plasmapheresis in severe sepsis and septic shock: A prospective, randomised, controlled trial. Intensive Care Med 2002; 28: 1434-9.
22. Nguyen TC HM, Han YY, Seidberg N, Carcillo JA. Randomized controlled trial of plasma exchange therapy for thrombocytopenia associated multiple organ failure in children. Ped Res 2001; 49: 42A.
23. van de Kerkhove MP, Hoekstra R, Chamuleau RA, van Gulik TM. Clinical application of bioartificial liver support systems. Ann Surg 2004; 240: 216-30.